2016
DOI: 10.1038/ejhg.2016.38
|View full text |Cite
|
Sign up to set email alerts
|

Genetic discovery in multi-ethnic populations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 13 publications
0
7
0
Order By: Relevance
“…The NOS3 gene is associated with coronary artery disease, migraine, vascular dysfunction, SVD, and ischemic stroke. 22,29,30,34 PLEKHG1 is associated with dementia and ischemic stroke, 35 and SH3PXD2A has been previously associated with total WMH and ischemic stroke. 19,25 The most notable associated vascular gene is COL4A2 that encodes for a subunit of type IV collagen, which has been associated with SVD, ischemic stroke, intracranial hemorrhage, and coronary artery disease.…”
Section: Discussionmentioning
confidence: 96%
See 1 more Smart Citation
“…The NOS3 gene is associated with coronary artery disease, migraine, vascular dysfunction, SVD, and ischemic stroke. 22,29,30,34 PLEKHG1 is associated with dementia and ischemic stroke, 35 and SH3PXD2A has been previously associated with total WMH and ischemic stroke. 19,25 The most notable associated vascular gene is COL4A2 that encodes for a subunit of type IV collagen, which has been associated with SVD, ischemic stroke, intracranial hemorrhage, and coronary artery disease.…”
Section: Discussionmentioning
confidence: 96%
“…19,25 The most notable associated vascular gene is COL4A2 that encodes for a subunit of type IV collagen, which has been associated with SVD, ischemic stroke, intracranial hemorrhage, and coronary artery disease. 31,[35][36][37][38] It is a proposed therapeutic target for the prevention of intracranial hemorrhage. 32,39 The association of this vascular gene with PVWMH and deep intracerebral hemorrhage is suggestive of…”
Section: Discussionmentioning
confidence: 99%
“…In addition, certain drugs may be less effective or even unsafe in some racial/ethnic groups due to genetic differences [ 12 ]. For GWAS, studies embracing ethnic diversity have been recognized as more powerful for gene mapping due to differences in allele frequency, effect size, haplotype background of causal variant(s), and LD across ethnicities [ 49 , 50 ], as well as factors that are broadly defined as social determinants of race including but not limited to differential pathogen invasion, environmental exposures, perceived discrimination and associated psychosocial stress [ 51 , 52 , 53 ]. We therefore consider it a pressing task to increase diversity in our genetic studies.…”
Section: Discussionmentioning
confidence: 99%
“…This calls into question the generalizability of research findings to ethnic minority groups. As statistical advances facilitate genomic analyses of ancestrally diverse populations [33, 34], we undertook a proof-of-concept GWAS (including the first 10 ancestry-informative PCs) in our ancestrally heterogeneous GENRA/SLESS cohort (supplementary Figs S7 and S8, available at Rheumatology Online). The genomic-inflation factor was 0.99, suggesting appropriate control for population stratification.…”
Section: Discussionmentioning
confidence: 99%